Earlier, sodium propionate was shown to promote apoptosis and autophagy pathways through a peroxisome proliferator activated receptor gamma (PPAR-γ)-dependent mechanism suggesting that the PPAR-γ/SCFAs axis could be targeted for the glioblastoma management (Filippone et al., 2022). Here, PPARG is linked to glioblastoma.